Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmicals提供苯達莫司汀知識產權組合的最新情況
United States Court Of Appeals For The Federal Circuit Affirmed The Previously Announced Decision By The United States District Court For The District Of Delaware Finding That Drug Applications Referencing Eagle Pharmaceuticals' Belrapzo (Bendamustine) Filed By Slayback Pharma And Apotex Did Not Infringe Eagle's Previously Issued '483 Patent
美國聯邦巡迴上訴法院確認了美國特拉華特區地方法院先前宣佈的裁決，認定Slayback Pharma和Apotex提交的引用鷹製藥公司Belrapzo（苯達莫司汀）的藥物申請沒有侵犯Eagle先前發佈的'483專利